C-Terminal Fibronectin Exerts Beneficial Effects in Reducing Tissue Damage and Modulating Macrophage Function in a Murine Septic Model

References

• van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17:407–420. doi:10.1038/nri.2017.36
   PubMed Web of Science ®Google Scholar
• Huang M, Cai S, Su J. The Pathogenesis of Sepsis and Potential Therapeutic Targets. Int J Mol Sci. 2019;20. doi:10.3390/ijms20215376
   PubMedGoogle Scholar
• Balk RA. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Dis Mon. 2004;50:168–213. doi:10.1016/j.disamonth.2003.12.003
   PubMed Web of Science ®Google Scholar
• Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am J Respir Crit Care Med. 2016;193:259–272. doi:10.1164/rccm.201504-0781OC
   PubMed Web of Science ®Google Scholar
• Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200–211. doi:10.1016/s0140-6736(19
   PubMed Web of Science ®Google Scholar
• Chen X, Liu Y, Gao Y, Shou S, Chai Y. The roles of macrophage polarization in the host immune response to sepsis. Int Immunopharmacol. 2021;96:107791. doi:10.1016/j.intimp.2021.107791
   PubMed Web of Science ®Google Scholar
• Cheng Y, Marion TN, Cao X, Wang W, Cao Y. Park 7: a Novel Therapeutic Target for Macrophages in Sepsis-Induced Immunosuppression. Front Immunol. 2018;9:2632. doi:10.3389/fimmu.2018.02632
   PubMedGoogle Scholar
• Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496:445–455. doi:10.1038/nature12034
   PubMed Web of Science ®Google Scholar
• Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm. 2013;2013:165974. doi:10.1155/2013/165974
   PubMed Web of Science ®Google Scholar
• Locati M, Curtale G, Mantovani A. Diversity, Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol. 2020;15:123–147. doi:10.1146/annurev-pathmechdis-012418-012718
   PubMed Web of Science ®Google Scholar
• Zhu W, Bao R, Fan X, et al. PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model. Mediators Inflamm. 2013;2013:361501. doi:10.1155/2013/361501
   PubMedGoogle Scholar
• Kyriazopoulou E, Giamarellos-Bourboulis EJ. Monitoring immunomodulation in patients with sepsis. Expert Rev Mol Diagn. 2021;21:17–29. doi:10.1080/14737159.2020.1851199
   PubMed Web of Science ®Google Scholar
• Sari MI, Ilyas S. The Expression Levels and Concentrations of PD-1 and PD-L1 Proteins in Septic Patients: a Systematic Review. Diagnostics. 2022;12. doi:10.3390/diagnostics12082004
   Google Scholar
• Okano M, Azuma M, Yoshino T, et al. Differential role of CD80 and CD86 molecules in the induction and the effector phases of allergic rhinitis in mice. Am J Respir Crit Care Med. 2001;164:1501–1507. doi:10.1164/ajrccm.164.8.2011072
   PubMedGoogle Scholar
• Flohé SB, Agrawal H, Flohé S, Rani M, Bangen JM, Schade FU. Diversity of interferon gamma and granulocyte-macrophage colony-stimulating factor in restoring immune dysfunction of dendritic cells and macrophages during polymicrobial sepsis. Mol Med. 2008;14:247–256. doi:10.2119/2007-00120.Flohe
   PubMedGoogle Scholar
• Yan X, Tu H, Liu Y, Chen T, Cao J. Interleukin-17D Aggravates Sepsis by Inhibiting Macrophage Phagocytosis. Crit Care Med. 2020;48:e58–e65. doi:10.1097/CCM.0000000000004070
   PubMedGoogle Scholar
• Miao J, Ye P, Lan J, et al. Paeonol promotes the phagocytic ability of macrophages through confining HMGB1 to the nucleus. Int Immunopharmacol. 2020;89:107068. doi:10.1016/j.intimp.2020.107068
   PubMedGoogle Scholar
• Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2001;2:907–916. doi:10.1038/ni1001-907
   PubMed Web of Science ®Google Scholar
• Winkler MS, Kluge S, Holzmann M, et al. Markers of nitric oxide are associated with sepsis severity: an observational study. Crit Care. 2017;21:189. doi:10.1186/s13054-017-1782-2
   PubMedGoogle Scholar
• Ruiz Martín G, Prieto Prieto J, Veiga de Cabo J, et al. Plasma fibronectin as a marker of sepsis. Int J Infect Dis. 2004;8:236–243. doi:10.1016/j.ijid.2003.10.005
   PubMedGoogle Scholar
• Stevens LE, Clemmer TP, Laub RM, Miya F, Robbins L. Fibronectin in severe sepsis. Surg Gynecol Obstet. 1986;162:222–228.
   PubMedGoogle Scholar
• Mamani M, Hashemi SH, Hajilooi M, Saedi F, Niayesh A, Fallah M. Evaluation of fibronectin and C-reactive protein levels in patients with sepsis: a case-control study. Acta Med Iran. 2012;50:404–410.
   PubMedGoogle Scholar
• Yang F, Zhang Y, Cui X, et al. Extraction of Cell-Free Whole Blood Plasma Using a Dielectrophoresis-Based Microfluidic Device. Biotechnol J. 2019;14:e1800181. doi:10.1002/biot.201800181
   PubMedGoogle Scholar
• Wu Y, Chen YZ, Huang HF, Chen P. Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice. Acta Pharmacol Sin. 2004;25:783–788.
   PubMedGoogle Scholar
• Wu LQ, Yong WY, Zhang T, et al. C-terminal heparin-binding domain polypeptide derived from plasma fibronectin, rhFNHC36, protects endotoxemia mice by preventing inflammatory responses and increasing the activity of Th lymphocytes. Int J Clin Exp Pathol. 2017;10:6453–6461.
   Google Scholar
• Dejager L, Pinheiro I, Dejonckheere E, Libert C. Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends Microbiol. 2011;19:198–208. doi:10.1016/j.tim.2011.01.001
   PubMed Web of Science ®Google Scholar
• Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 2009;4:31–36. doi:10.1038/nprot.2008.214
   PubMed Web of Science ®Google Scholar
• Ott TR, Pahuja A, Lio FM, et al. A high-throughput chemotaxis assay for pharmacological characterization of chemokine receptors: utilization of U937 monocytic cells. J Pharmacol Toxicol Methods. 2005;51:105–114. doi:10.1016/j.vascn.2004.10.001
   PubMedGoogle Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6:a016295. doi:10.1101/cshperspect.a016295
   PubMed Web of Science ®Google Scholar
• MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997;15:323–350. doi:10.1146/annurev.immunol.15.1.323
   PubMed Web of Science ®Google Scholar
• Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011;11:762–774. doi:10.1038/nri3070
   PubMed Web of Science ®Google Scholar
• Nakamori Y, Park EJ, Shimaoka M. Immune Deregulation in Sepsis and Septic Shock: reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway. Front Immunol. 2020;11:624279. doi:10.3389/fimmu.2020.624279
   PubMed Web of Science ®Google Scholar
• Hunt A. Sepsis: an overview of the signs, symptoms, diagnosis, treatment and pathophysiology. Emerg Nurse. 2019;27:32–41. doi:10.7748/en.2019.e1926
   PubMedGoogle Scholar
• Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–228. doi:10.1007/s00134-012-2769-8
   PubMed Web of Science ®Google Scholar
• von Dessauer B, Bongain J, Molina V, Quilodrán J, Castillo R, Rodrigo R. Oxidative stress as a novel target in pediatric sepsis management. J Crit Care. 2011;26:103.e101–107. doi:10.1016/j.jcrc.2010.05.001
   Google Scholar
• Cassado Ados A, D’império lima MR, Bortoluci KR. Revisiting mouse peritoneal macrophages: heterogeneity, development, and function. Front Immunol. 2015;6:225. doi:10.3389/fimmu.2015.00225
   PubMed Web of Science ®Google Scholar
• Murray HW, Juangbhanich CW, Nathan CF, Cohn ZA. Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates. J Exp Med. 1979;150:950–964. doi:10.1084/jem.150.4.950
   Google Scholar
• Qiu P, Liu Y, Zhang J. Review: the Role and Mechanisms of Macrophage Autophagy in Sepsis. Inflammation. 2019;42:6–19. doi:10.1007/s10753-018-0890-8
   PubMed Web of Science ®Google Scholar
• Weiss G, Schaible UE. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev. 2015;264:182–203. doi:10.1111/imr.12266
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005;4:281–286. doi:10.2174/1568010054022024
   PubMedGoogle Scholar
• Kumar V. Targeting macrophage immunometabolism: dawn in the darkness of sepsis. Int Immunopharmacol. 2018;58:173–185. doi:10.1016/j.intimp.2018.03.005
   PubMed Web of Science ®Google Scholar
• Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock. 1993;41:77–81.
   PubMedGoogle Scholar
• Lambden S. Bench to bedside review: therapeutic modulation of nitric oxide in sepsis-an update. Intensive Care Med Exp. 2019;7:64. doi:10.1186/s40635-019-0274-x
   PubMedGoogle Scholar
• Velazquez-Salinas L, Verdugo-Rodriguez A, Rodriguez LL, Borca MV. The Role of Interleukin 6 During Viral Infections. Front Microbiol. 2019;10:1057. doi:10.3389/fmicb.2019.01057
   PubMed Web of Science ®Google Scholar
• Ruytinx P, Proost P, Van Damme J, Struyf S. Chemokine-Induced Macrophage Polarization in Inflammatory Conditions. Front Immunol. 2018;9:1930. doi:10.3389/fimmu.2018.01930
   PubMed Web of Science ®Google Scholar
• Chen R, Zhou L. PD-1 signaling pathway in sepsis: does it have a future? Clin Immunol. 2021;229:108742. doi:10.1016/j.clim.2021.108742
   PubMed Web of Science ®Google Scholar